Skip to content

Abbott ABT Investments

Investments at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW
$285.6M+2.8%
DexCom logo
DexComDXCM
Agilent Technologies logo
Agilent TechnologiesA
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's investments?
Abbott (ABT) reported investments of $1.09B in Q1 2026.
How has Abbott's investments changed year-over-year?
Abbott's investments increased by 20.2% year-over-year, from $907M to $1.09B.
What is the long-term trend for Abbott's investments?
Over 5 years (2020 to 2025), Abbott's investments has grown at a 2.3% compound annual growth rate (CAGR), from $821M to $918M.